BioSante Pharmaceuticals Announces Reverse Stock Split in Order to Maintain NASDAQ Listing
20:01 EDT 31 May 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today that it
intends to effect a reverse split of its common stock and class C
special stock at a ratio of 1-for-6. The reverse stock split will become
effective at 5:00 p...
Other Sources for this Article
For Investors:
The Trout Group LLC
Tricia Swanson, (646)
378-2953
tswanson@troutgroup.com
or
For
Media:
Harris D. McKinney, Inc.
Alan Zachary, 312-506-5220
azachary@harrisdmckinney.com
More From BioPortfolio on "BioSante Pharmaceuticals Announces Reverse Stock Split in Order to Maintain NASDAQ Listing"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
